Introduction
============

Monitoring cardiac output (CO) allows early detection of haemodynamic instability and may be used to guide intensive care, aiming to reduce morbidity and mortality in high-risk patients \[[@B1]\]. In the past decade, continuous cardiac output (CCO) was commonly obtained by pulmonary artery catheter (PAC) with integrated heating filaments. The risk--benefit ratio of right heart catheterisation simply for CO determination has been questioned due to associated complications and the availability of less invasive alternatives \[[@B2]\]. Various monitor devices have been recently introduced into clinical practise that use the arterial pressure waveform to calculate CO on a beat-to-beat basis, such as the LiDCO™*plus*system using continuous cardiac output by pulse power analysis (PulseCO) and the PiCCO *plus*system using continuous cardiac output by pulse contour analysis (PCCO). Since arterial and central venous catheters are often already used to monitor critically ill patients, these techniques are not additionally invasive.

Several clinical studies have been performed on intensive care patients showing good agreement and correlation of the aforementioned methods of CCO determination with thermodilution or indicator-based techniques \[[@B3]-[@B10]\]. Some authors, however, recently questioned the reliability of these methods when acute changes of CO occur \[[@B11]-[@B14]\]. Therefore it is of high clinical interest to know whether the CCO method used is able to detect sudden CO changes, as frequently observed during haemorrhage, fluid loading or vasopressor administration \[[@B15]\]. Moreover, critically ill patients often present with intra-abdominal hypertension (IAH) \[[@B16]\]. Preliminary data by Malbrain and colleagues indicated unacceptable high limits of agreement of different invasive CCO measurements in 10 patients with IAH \[[@B17]\]. Reliability of CCO measurement during IAH and volume loading has not yet been elucidated in a controlled experimental setup. Increased intra-abdominal pressure is likely to modify several factors known to impact arterial waveform, such as chest wall compliance and arterial elastance, thereby potentially deteriorating agreement between the CO derived from thermodilution and derived from the arterial waveform.

The aim of the present study was to investigate whether PulseCO and PCCO -- methods derived from the arterial waveform -- and continuous assessment of continuous cardiac output by pulmonary artery catheter thermodilution (CCO~PAC~) are able to detect a volume-induced change of CO during IAH when compared with bolus transcardiopulmonary thermodilution cardiac output (CO~TCP~). Further, the level of agreement between these CCO values and CO~TCP~during IAH was determined. Finally, we analysed the impact of calibration on the accuracy of continuous beat-to-beat CO methods.

Materials and methods
=====================

The present study was reviewed and approved by the local Animal Investigation Committee. The animals (10 healthy German domestic pigs, 58 ± 8 kg) were managed in accordance with our institutional guidelines, which are based on the *Guide for the Care and Use of Laboratory Animals*published by the National Institute of Health (NIH Publication No. 88.23, revised 1996).

The animals were fasted overnight, but had free access to water. The pigs were premedicated with the neuroleptic azaperone (4 to 8 mg/kg intramuscularly) and atropine (0.01 to 0.05 mg/kg intramuscularly) 1 hour before induction of anaesthesia with a bolus dose of ketamine (2 mg/kg intramuscularly), propofol (2 to 4 mg/kg intravenously) and sufentanil (0.3 μg/kg intravenously) given via an ear vein. After intubation with a cuffed endotracheal tube (internal diameter, 8.5 mm), the pigs were ventilated using a volume-controlled ventilator (Avea; Viasys Healthcare, Yorba Linda, CA, USA) with 10 ml/kg tidal volume, a positive end-expiratory pressure of 5 cmH~2~O, an inspiration:expiration ratio of 1:1.5 and a fraction of inspired oxygenof 0.35. The respiratory rate (12 to 18 breaths/min) was adjusted to maintain normocapnea (pressure of end-tidal CO~2~= 35 to 45 mmHg). Oxygen saturation was monitored by a pulse oxymeter placed on the ear (M-CaiOV; Datex-Ohmeda, Helsinki, Finland).

Anaesthesia was maintained with a continuous infusion of propofol (6 to 8 mg/kg/hour) and sufentanil (0.3 μg/kg/hour), and muscle relaxation was provided by continuous infusion of pancuronium (0.2 mg/kg/hour) to ensure suppression of spontaneous gasping. In our experience, the animals do not respond to painful or auditory stimuli under this anaesthetic regimen when the paralysing agent is withheld, and the loading dose of ketamine and propofol subsides.

Ringer solution (5 ml/kg/hour) was administered during instrumentation. For induction of IAH, a Verres needle was inserted via a small infra-umbilical incision into the intra-abdominal cavity. The Verres needle was then connected to an electronic variable-flow insufflator (Wolf 2154701; Wolf GmbH, Knittlingen, Germany) for direct intra-abdominal pressure measurement and induction of IAH due to carbon dioxide pneumoperitoneum. The intra-abdominal pressure was measured in a supine position at end expiration.

Cardiac output techniques
-------------------------

### Pulse power analysis

PulseCO is a method integrated into the LiDCO™*plus*monitor (LiDCO™ Systems, London, UK). PulseCO uses pulse power analysis to determine the CCO by analysing the entire arterial waveform, and is not based on the morphology of the pulse contour. The system calculates the nominal stroke volume after a pressure-to-volume transformation using a curvilinear pressure/volume relationship. The nominal stroke volume is converted to the actual stroke volume by calibration of the algorithm based on lithium dilution using a bolus of 0.002 mmol/kg isotonic lithium chloride that was injected into the proximal port of the PAC. The lithium dilution curve was measured by a lithium ion-selective electrode (LiDCO, London, UK) located in a femoral arterial line, which was connected to the LiDCO device. Calibration of PulseCO was performed before muscle relaxation, because neuromuscular blockers may react with the lithium electrode.

### Pulse contour analysis

PCCO is a method integrated into the PiCCO *plus*monitor (version 6.0; Pulsion Medical Systems, Munich, Germany). PCCO uses pulse contour analysis for calculation of the CCO and is based on a modified algorithm originally described by Wesseling and colleagues \[[@B18]\]. This algorithm enables continuous calculation of the stroke volume by measuring the systolic portion of the aortic pressure waveform and dividing the area under the curve by the individual aortic impedance. The PCCO device therefore needs to be calibrated by transcardiopulmonary thermodilution.

### Continuous thermodilution by pulmonary artery catheter

CCO~PAC~is based on a semicontinuous pulsed warm thermodilution technique integrated into a PAC that is connected to a computer system (Vigilance Monitor; Baxter Edwards Critical Care, Irvine, CA, USA). The PAC (7.5-Fr Swan--Ganz CCO; Baxter Healthcare Corporation, Irvine, CA, USA) was inserted via an 8.5-Fr transducer into the right internal jugular vein for measuring the central venous pressure (CVP) and the pulmonary artery occlusion pressure (PAOP) and for CCO~PAC~recording.

### Intermittent bolus transcardiopulmonary thermodilution

CO~TCP~is a bolus transcardiopulmonary thermodilution technique and served as the reference method and calibration method for PCCO. A 5-Fr thermistor-tipped arterial catheter (Pulsion Medical Systems) was inserted percutaneously into the right femoral artery, which was connected to the PiCCO *plus*monitor. A 10 ml bolus of cold (\<8°C) saline was injected three times randomly assigned to the respiratory cycle into the proximal port of the PAC. Furthermore, an implemented algorithm enables calculation of the global end-diastolic volume (GEDV) as a volumetric variable of preload.

Experimental protocol
---------------------

The experimental protocol is presented in Figure [1](#F1){ref-type="fig"}.

![**Experimental protocol**. The methods used were continuous cardiac output by pulse contour analysis (PCCO; PiCCO system), continuous cardiac output by pulse power analysis (PulseCO; LiDCO system), continuous cardiac output by pulmonary artery catheter thermodilution (CCO~PAC~), and bolus transcardiopulmonary thermodilution cardiac output (CO~TCP~). PCCO was measured before recalibration (PCCO~pre~) and after recalibration (PCCO~recal~) by CO~TCP~. Experimental steps: BL, baseline; + Fluid, fluid loading; IAH, intra-abdominal hypertension; IAH + Fluid, second fluid load at IAH. HES, hydroxyl-ethyl starch 6%; IAP, intra-abdominal pressure; n.a., not applicable.](cc7102-1){#F1}

At the end of surgical preparation, at least 15 minutes were allowed for stabilisation. After taking baseline values, all animals received a fluid load of 500 ml hydroxyl-ethyl starch 6%. Equilibrium was expected after 10 minutes and measurements were repeated. Carbon dioxide was subsequently inflated into the abdominal cavity. IAH was assumed when the abdominal pressure was increased to at least 20 mmHg, reaching IAH grade III/IV according to the 2004 International Abdominal Compartment Syndrome Consensus Definitions Conference \[[@B19]\].

CO measurements were recorded after another stabilisation period of 10 minutes and again after a second fluid load of 500 ml hydroxyl-ethyl starch 6%. We recorded PCCO values 2 minutes before recalibration (PCCO~pre~) and 2 minutes after recalibration (PCCO~recal~) by CO~TCP~to control for a calibration effect. To avoid interference of CCO~PAC~with the bolus of ice-cold saline for CO~TCP~calibration, CO~TCP~was obtained at least 2 minutes in advance of CCO~PAC~recording. CCO~PAC~sampling was started after obtaining the CO~TCP~. PulseCO remained uncalibrated after baseline calibration throughout the experimental period. According to the manufacturer, calibration based on CO measured by lithium dilution or every other validated CO method is needed only once every 8 hours. PulseCO, PCCO and CCO~PAC~values were recorded and averaged during a period of 1 minute.

Statistical analysis
--------------------

Data are reported as the mean ± standard deviation (SD) unless otherwise specified. Statistical comparisons were performed using commercially available statistics software (GraphPad Prism 4; Graphpad Sofware Inc., San Diego, CA, USA).

Bland--Altman analysis was used to compare CO values by different measuring methods \[[@B20]\]. The bias represents the systemic error between two methods, and was defined as the mean difference between CO~A~and CO~B~values. Upper and lower limits of agreement, calculated as the bias ± 2 SDs, define the range in which 95% of the differences are expected to lie. The percentage error (PE) was calculated as reported by Critchley and Critchley \[[@B21]\], as limits of agreement (2 SD) divided by the mean CO from the two methods:

$$PE(\%) = \frac{2SD_{bias}}{(CO_{A} + CO_{B})/2} \cdot 100$$

In addition, data pairs were analysed using linear correlations and calculation of the coefficient of determination (*r*^2^). CO values after fluid loadings or initiation of IAH were compared using a paired *t*test. Furthermore, ΔCO was calculated as the percentage change of each CO method and was plotted against ΔCO~TCP~using linear regression and Bland--Altman analysis. *P*\< 0.05 was considered statistically significant.

Results
=======

Nine animals were included in the final analysis. One pig was excluded from further analysis due to injury of the splenic vein by the Verres needle and a fatal outcome. All haemodynamic devices were installed and calibrated properly and no complications were associated with any of the devices. All animals were haemodynamically stable throughout the study period, no arrhythmias occurred, and no inotropic or antihypertensive drugs were administered. Pneumoperitoneum increased the intra-abdominal pressure by 17.7 ± 3.5 mmHg, and reduced chest wall compliance significantly by 64 ± 8%.

The haemodynamic variables are displayed in Table [1](#T1){ref-type="table"}. The mean arterial pressure, GEDV, PulseCO, PCCO~pre~, PCCO~recal~, CO~TCP~and CCO~PAC~significantly increased after fluid loading at baseline, whereas the heart rate, CVP and PAOP remained unchanged. IAH significantly increased CVP and PAOP, but did not change the mean arterial pressure, heart rate, GEDV or CO values. Fluid loading during IAH did not significantly change the mean arterial pressure, heart rate, CVP, PAOP or GEDV, while CO~TCP~, CCO~PAC~and PCCO~recal~indicated a significant increase in CO. PulseCO and PCCO~pre~, however, were unable to reflect an increase of CO following fluid loading during IAH. Changes of CO determined by different methods throughout the experimental period are presented in Figure [2a](#F2){ref-type="fig"}. Individual time responses of each CO parameter are presented in detail (see Additional file [1](#S1){ref-type="supplementary-material"}, Figure S2).

![**Distribution and bias of cardiac output methods**. **(a)**Cardiac output (CO) measured by the different CO methods at each experimental step. **(b)**Bias and precision (standard deviation (SD)) between bolus transcardiopulmonary thermodilution cardiac output (CO~TCP~) and the different CO methods at each experimental step. PulseCO, continuous cardiac output by pulse power analysis (LiDCO system); PCCO, continuous cardiac output by pulse contour analysis (PiCCO system); CCO~PAC~, continuous cardiac output by pulmonary artery catheter thermodilution. PCCO was measured before recalibration (PCCO~pre~) and after recalibration (PCCO~recal~) by CO~TCP~. \**P*\< 0.05 versus the previous experimental stage (PCCO~pre~versus previous PCCO~recal~). ^\#^Methods not interchangeable according to Critchley and Critchley \[[@B21]\]. Filled symbols, calibrated measures. Experimental steps: BL, baseline; + Fluid, fluid loading; IAH, intra-abdominal hypertension; IAH + Fluid, second fluid load at IAH. IAP, intra-abdominal pressure; na, not applicable; SEM, standard error of the mean.](cc7102-2){#F2}

###### 

Haemodynamic data at each experimental step

  Haemodynamic variable                        Baseline    Fluid loading   IAH           IAH + Fluid
  -------------------------------------------- ----------- --------------- ------------- -----------------
  Mean arterial pressure (mmHg)                77 ± 20     99 ± 18\*       109 ± 13\*    112 ± 16\*
  Heart rate (beats/min)                       87 ± 18     92 ± 18         92 ± 13       99 ± 12\*
  Central venous pressure (mmHg)               5 ± 2       7 ± 2           12 ± 4\*^†^   12 ± 3\*^†^
  Pulmonary artery occlusion pressure (mmHg)   7 ± 2       11 ± 3          16 ± 6\*^†^   16 ± 3\*^†^
  Intra-abdominal pressure (mmHg)              7 ± 2       7 ± 3           25 ± 3\*^†^   27 ± 4\*^†^
  Chest wall compliance (ml/cmH~2~O)           58 ± 24     65 ± 22         22 ± 5\*^†^   21 ± 4\*^†^
  Systemic vascular resistance (dyn·s/cm^5^)   963 ± 392   1006 ± 356      1038 ± 192    994 ± 303
  Global end-diastolic volume (ml)             767 ± 164   883 ± 214\*     928 ± 172\*   997 ± 217\*^†^
  PulseCO (l/min)                              6.4 ± 2.0   7.1 ± 2.7\*     6.8 ± 2.5     7.0 ± 2.8
  PCCO~pre~(l/min)                             n.a.        7.1 ± 1.1\*     6.8 ± 2.0     7.9 ± 1.9
  CO~TCP~(l/min)                               6.2 ± 1.6   7.5 ± 2.1\*     8.0 ± 1.9\*   9.4 ± 2.4\*^†‡^
  PCCO~recal~(l/min)                           6.2 ± 1.6   7.5 ± 2.1\*     8.0 ± 1.9\*   9.4 ± 2.4\*^†‡^
  CCO~PAC~(l/min)                              6.4 ± 1.4   7.6 ± 1.4\*     7.7 ± 1.5\*   9.1 ± 2.1\*^†‡^

Data presented as the mean ± standard deviation. IAH, intra-abdominal hypertension; IAH + Fluid, second fluid load at IAH; PulseCO, continuous cardiac output by pulse power analysis; PCCO~pre~, continuous cardiac output by pulse contour analysis before calibration; CO~TCP~, bolus transcardiopulmonary thermodilution cardiac output; PCCO~recal~, continuous cardiac output by pulse contour analysis after recalibration; CCO~PAC~, continuous cardiac output by pulmonary artery catheter thermodilution. \**P*\< 0.05 versus BL; ^†^*P*\< 0.05 versus + Fluid; ^‡^*P*\< 0.05 versus IAH (PCCO~pre~versus previous PCCO~recal~). n.a., not applicable.

Results of ΔCO comparison by Bland--Altman analysis and linear regression analysis are presented in Table [2](#T2){ref-type="table"} (for further details, see Additional file [1](#S1){ref-type="supplementary-material"}, Figure S1). ΔCCO~PAC~and ΔPCCO~recal~showed better agreement with ΔCO~TCP~than uncalibrated ΔPulseCO or ΔPCCO~pre~.

###### 

Bland--Altman analysis and linear regression analysis of changes in cardiac output

                             Bias (%)   Precision (%)   95% limits of agreement (%)   *r*^2^
  -------------------------- ---------- --------------- ----------------------------- --------
  ΔCO~TCP~and ΔPulseCO       12         19              -26 to 50                     0.38
  ΔCO~TCP~and ΔPCCO~pre~     14         18              -22 to 51                     0.32
  ΔCO~TCP~and ΔPCCO~recal~   -1         5               -10 to 9                      0.94
  ΔCO~TCP~and ΔCCO~PAC~      2          14              -26 to 30                     0.47

Bias (mean difference), precision (standard deviation of bias), 95% limits of agreement, and correlation coefficient (*r*^2^) between changes (Δ) of CO measured by ΔPulseCO, ΔPCCO~pre~, ΔPCCO~recal~and ΔCCO~PAC~compared with ΔCO~TCP~. CO~TCP~, bolus transcardiopulmonary thermodilution cardiac output; PulseCO, continuous cardiac output by pulse power analysis; PCCO~pre~, continuous cardiac output by pulse contour analysis before calibration; PCCO~recal~, continuous cardiac output by pulse contour analysis after recalibration; CCO~PAC~, continuous cardiac output by pulmonary artery catheter thermodilution.

Bland--Altman analysis revealed an overall (pooled data) bias ± SD (PE) between CO~TCP~and PulseCO of 1.0 ± 1.5 l/min (41.7%), between CO~TCP~and PCCO~pre~of 1.0 ± 1.1 l/min (27.5%), and between CO~TCP~and CCO~PAC~of 0.0 ± 0.9 l/min (23.3%). Figure [3a](#F3){ref-type="fig"} to [3f](#F3){ref-type="fig"} present Bland--Altman plots and correlation of pooled data comparing PulseCO, PCCO~pre~and CCO~PAC~with CO~TCP~.

![**Scatter plots and Bland--Altman plots of pooled data pairs**. Scatter plots (left-hand side) and Bland--Altman plots (right-hand side) of pooled data pairs between **(a)**and **(b)**bolus transcardiopulmonary thermodilution cardiac output (CO~TCP~) and continuous cardiac output by pulse power analysis (PulseCO; LiDCO system), **(c)**and **(d)**between CO~TCP~and continuous cardiac output by pulse contour analysis before recalibration (PCCO~pre~; PiCCO system), and **(e)**and **(f)**between CO~TCP~and continuous cardiac output by pulmonary artery catheter thermodilution (CCO~PAC~). (a), (c), (e) Scatter plots include line of identity (dotted line). (b), (d), (f) Bland--Altman plots include bias (solid lines) and limits of agreement (dotted lines).](cc7102-3){#F3}

The bias and precision (SD) between the examined CO methods and CO~TCP~at individual experimental steps are displayed in Figure [2b](#F2){ref-type="fig"}. The bias between CO~TCP~and the different CO methods was low at baseline, as criteria of interchangeability (PE \<30%) were observed for all CO methods \[[@B21]\]. Fluid loading did not change the bias between methods significantly. After application of IAH, the bias between CO~TCP~and PulseCO and between CO~TCP~and PCCO~pre~increased, but this was only significant for PCCO~pre~(*P*\< 0.05). Whereas fluid loading at baseline did not affect the bias between methods, the bias between CO~TCP~and PulseCO and between CO~TCP~and PCCO~pre~was significantly increased after fluid loading at IAH (*P*\< 0.05). Calibration of PCCO~pre~reduced the bias significantly, as the bias between PCCO~recal~and CO~TCP~was low. Detailed results of Bland--Altman analysis and Pearson correlation comparisons between the different CCO methods and CO~TCP~at individual steps are available (see Additional file [1](#S1){ref-type="supplementary-material"}, Table S1).

Discussion
==========

The main findings of our experimental animal study are as follows. Firstly, at baseline without IAH, all CO methods showed acceptable agreement and reflected volume loading with an increase in CO. In contrast, IAH affects CO methods based on arterial waveform analysis in their ability to accurately indicate an increase in CO following fluid loading. Finally, recalibration of PCCO restored the system\'s accuracy.

The present study is the first on the agreement between three CCO methods and one intermittent bolus-thermodilution CO method during IAH and subsequent fluid loading. Research in the field of CCO monitoring has increased in recent years, as better evaluation of changes in a patient\'s haemodynamic status can facilitate therapy. Therefore it is of great interest whether these methods are able to reflect acute changes in CO induced by fluid loading under clinically relevant settings such as IAH.

Our results showed acceptable agreement of pooled CO data between CO~TCP~, PCCO~pre~+ PCCO~recal~and CCO~PAC~, whereas continuous beat-to-beat analysis by PulseCO calibrated only once underestimated the CO and failed interchangeability as defined by Critchley and Critchley \[[@B21]\].

With respect to CCO~PAC~versus CO~TCP~and CCO~PAC~versus PCCO, comparable agreement and correlation have been reported in several previous studies \[[@B22],[@B23]\]. Compared with CO~TCP~, PCCO~recal~showed lower bias and lower PE than PCCO~pre~, a result expected intuitively. Volume loading in addition to IAH resulted in a significant increase of the CO measured by thermodilution techniques (CCO~PAC~and CO~TCP~). In contrast, beat-to-beat CO methods such as PulseCO and PCCO~pre~did not reflect the increase in CO accurately in the presence of IAH. The bias between PulseCO and PCCO~pre~versus CO~TCP~was significant after the second fluid load. Since the variability of bolus thermodilution is about 15%, we suggest that a mean bias within 15% of average CO can be clinically accepted. Recalibration of PCCO, as indicated by PCCO~recal~, results in a significant reduction of bias.

Taken together these findings emphasise that monitors tracking beat-to-beat CO benefit from frequent calibrations during changing loading conditions or changes of variables potentially influencing the underlying calculation algorithm, such as IAH.

All of the CO monitors showed clinically acceptable \[[@B21]\] agreement at baseline. The increase of CO due to fluid loading without IAH was also comparably reflected by all CO methods. The bias between methods remained unchanged. PulseCO failed interchangeability with CO~TCP~, however, as the PE increased clearly above 30% after fluid loading. Our data therefore suggest that PulseCO does not reliably indicate rapid haemodynamic changes following fluid loading. Similarly, Cooper and Muir recently reported PE \>90% between PulseCO and lithium dilution CO after fluid resuscitation in haemorrhagic dogs \[[@B12]\].

While IAH reduced chest wall compliance and increased the CVP and PAOP, it did not significantly influence the CO. It is well known that cardiac filling pressures such as the CVP or PAOP in patients with IAH may be misleading, by falsely indicating increased preload \[[@B24]\]. Contrarily, preload during IAH may even be decreased due to substantial reductions in venous return, which is more pronounced in hypovolaemic patients. In the present study, however, the GEDV indicated normovolaemic conditions at baseline and no changes of preload due to IAH occurred. Consequently, it is not surprising that CO was not affected by IAH, which has been described previously \[[@B25]\].

There is still an ongoing debate about CO measurement derived from arterial waveform analysis and its ability to track changes of CO. In the present study, uncalibrated CCO methods were not able to reflect changes in CO appropriately. Several studies have shown good agreement of PulseCO with thermodilution or indicator-based CO methods in postsurgical intensive care patients \[[@B7]-[@B9]\]. On the other hand, Yamashita and colleagues reported that CO measured by PulseCO was not interchangeable with thermodilution during cardiac surgery \[[@B14]\]. Cooper and Muir \[[@B12]\] have shown only a moderate decline of PulseCO after induced haemorrhage in healthy dogs, with significant bias between PulseCO and lithium indicator dilution CO. The CO changes due to changes of intravascular volume might therefore not be adequately tracked by PulseCO. The authors concluded that false transformation of arterial pressure difference by PulseCO and changes of arterial compliance are possible explanations for the lack of accuracy to depict changes in CO. In the present study, PulseCO was only calibrated by the lithium dilution technique at baseline. Because of continuous application of neuromuscular blocking agents, a repeated calibration with lithium may be hampered due to interactions at the lithium electrode \[[@B9]\]. A calibration with another thermodilution technique is possible but this does not represent clinical practise and loses the advantage of being less invasive.

In contrast to PulseCO, PCCO was calibrated at each experimental step. A direct comparison of PCCO and PulseCO in the present study is therefore difficult. By calibrating PCCO repeatedly, it was already adjusted to the latest changes of vascular impedance. Interestingly, both PCCO~pre~and PulseCO underestimated CO after fluid loading in the presence of IAH with high bias compared with CO~TCP~. Our group recently reported high bias between uncalibrated PCCO and bolus pulmonary artery thermodilution CO in pigs during haemorrhage and norepinephrine administration \[[@B11]\]. In this study, uncalibrated PCCO did not reflect decreased CO as indicated by the PAC during a phlebotomy of almost 2 l -- most probably due to failure to identify the dicrotic notch during a substantially increased heart rate. These findings were confirmed by Piehl and colleagues \[[@B26]\]. Additionally, Rodig and colleagues \[[@B2]\] reported a significant increase in bias between PCCO and CO~TCP~after cardiopulmonary bypass and vasopressor administration, most probably due to an increase in systemic vascular resistance. Sander and colleagues recommended frequent recalibration of PCCO after cardiopulmonary bypass due to changes in systemic vascular resistance \[[@B27]\]. In our study, however, systemic vascular resistance had no influence on the bias between methods.

The PCCO algorithm is based on the windkessel model by Otto Frank \[[@B28]\], including three major individual properties: aortic/arterial compliance, characteristic impedance, and peripheral vascular resistance. Calibration of PCCO by CO~TCP~enables the PCCO algorithm to correct for these three elements by calculating individual aortal compliance and systemic vascular resistance, and furthermore adjusting to aortic impedance. The ability of PCCO~pre~to accurately detect changes in CO due to fluid loading was hampered in the presence of IAH, however, whereas it was preserved at baseline. With respect to the effects of IAH, our results suggest that, due to reduced chest wall compliance, increased pleural and airway pressures are increasingly transmitted to the cardiac chambers, thereby reducing effective transmural pressure. Methods based on arterial waveform analysis are consequently prone to error in reflecting abrupt changes in CO, without an implemented algorithm to detect and correct for changes in vascular impedance as induced by IAH. The clinician therefore needs to consequently recalibrate the CCO based on arterial waveform analysis before any major change in therapy is initiated.

Our study has some limitations. The present study is an animal study and extrapolation to humans should be done with caution, and the reader should have this in mind. CCO~PAC~was obtained 2 minutes after bolus thermodilution, and hence a minor influence by recirculation of cold fluid is possible.

Conclusion
==========

All of the examined CO methods showed good agreement at baseline. There are limitations, however, in the ability of uncalibrated continuous CO methods based on arterial waveform analysis to accurately track changes in CO after fluid loading during IAH. The trend for underestimation of CO by PulseCO and PCCO~pre~documented in the present study could have clinical consequences. PCCO and PulseCO should be used with caution when assessing changes in CO after fluid loading, and should be recalibrated before any major change in therapy is initiated.

Key messages
============

• CO measured by PulseCO, PCCO and CCO~PAC~showed good agreement with CO~TCP~without IAH, and reflected an increase in CO following fluid loading.

• Induction of IAH due to pneumoperitoneum did not significantly influence CO measured by PulseCO, PCCO, CCO~PAC~and CO~TCP~.

• At IAH, an increase in CO following fluid loading was indicated by calibrated PCCO, CCO~PAC~and CO~TCP~but not by uncalibrated CCO methods using arterial waveform analysis, such as PulseCO and PCCO.

• Recalibration of CCO parameters based on arterial waveform analysis should be done before any major change in therapy is initiated.

Abbreviations
=============

CCO: continuous cardiac output; CCO~PAC~: continuous cardiac output by pulmonary artery catheter thermodilution; CO: cardiac output; CO~TCP~: bolus transcardiopulmonary thermodilution cardiac output; CVP: central venous pressure; GEDV: global end-diastolic volume; IAH: intra-abdominal hypertension; PAC: pulmonary artery catheter; PAOP: pulmonary artery occlusion pressure; PCCO: continuous cardiac output by pulse contour analysis; PCCO~pre~: continuous cardiac output by pulse contour analysis before calibration; PCCO~recal~: continuous cardiac output by pulse contour analysis after recalibration; PE: percentage error; PulseCO: continuous cardiac output by pulse power analysis; SD: standard deviation.
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